Back to results
US 2021/0275549 A1Published application
Novel formulations
AssigneeAeromics, Inc.
InventorsMarc F. PELLETIER, Paul Robert MCGUIRK, George William FARR
Life of this patent
Estimating the term…
Abstract
Provided are novel formulations of 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate as described below and uses thereof.
Claims16
1-87. (canceled)
A pharmaceutical composition comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate (Formula I)
- and one or more Bronsted bases, wherein the one or more Bronsted bases are an amine and/or a salt thereof, and the pharmaceutical composition comprises <2% N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide after one week at room temperature.
Dependencies are inferred from the claim text.